Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.382ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.382ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.356EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.356ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.356ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.356EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.356EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.356ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.356ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.376EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.376EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.376ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.376ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.376EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.376EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.376ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.376ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.70EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.70ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.70ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.70EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.70EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.42EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.42ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.42ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.42EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.42EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.428EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.428ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.428ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.428EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.428EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.428ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.428ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.374EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.374EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.374ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.374ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.374EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.374EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.374ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.374ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used